Health your username May 4, 2021 On April 30, the Tenth Circuit issued a non-precedential opinion in a case by the estate of professor Dr. Donald L. Robertson against his former employer, Brigham Young University (BYU) over a medical discovery with big ramifications. Previously, the district court denied the plaintiff’s leave to amend the complaint to add claims for breach of contract and misappropriation of trade secrets as futile. The opinion explains that three biochemists at BYU discovered the COX-2 enzyme on an unspecified date. The discovery was reportedly shared with one of the nation’s largest pharmaceutical companies, which used the information to develop the blockbuster drug known as “Celebrex.” BYU sued the pharmaceutical company and settled in 2012 for $450 million, and after paying its attorneys’ fees, kept 55% for itself and agreed to distribute the other 45% to the biochemists, including Robertson.